The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 10, 2003, Pages 1447-1454

  Oliveira, I O ^a,b   Lhullier, C ^a   Brum, I S ^a   Spritzer, P M ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

5 reductase; Hair follicle; Hirsutism; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; BETA 2 MICROGLOBULIN; ISOENZYME; STEROID 5ALPHA REDUCTASE;

ABSORPTION; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; FEMALE; GENE EXPRESSION; HAIR ANALYSIS; HAIR FOLLICLE; HAIR GROWTH; HIRSUTISM; HORMONE ACTION; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; KERATINOCYTE; MALE; OVARY POLYCYSTIC DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; SCALP;

EID: 0142241406     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2003001000024     Document Type: Article

References (40)

1. Kuttenn F, Mowszowicz I, Schaison G & Mauvais-Jarvis P (1977). Androgen production and skin metabolism in hirsutism. Journal of Endocrinology, 75: 83-91.
2. New MI, Lorenzen F, Lerner AJ et al. (1983). Genotyping steroid 21 hydroxylase deficiency: hormonal reference data. Journal of Clinical Endocrinology and Metabolism, 57: 320-326.
3. Azziz R, Carmina E & Sawaya ME (2000). Idiopathic hirsutism. Endocrine Reviews, 21: 347-362.
4. Mauvais-Jarvis P, Bercovici JP & Gauthier F (1969). In vivo studies on testosterone metabolism by skin of normal males and patients with the syndrome of testicular feminization. Journal of Clinical Endocrinology and Metabolism, 29: 417-421.
5. Griffin JE & Wilson JD (1977). Studies on the pathogenesis of the incomplete forms of androgen resistance in man. Journal of Clinical Endocrinology and Metabolism, 45: 1137-1143.
6. Kuttenn F, Mowszowicz I, Wright F, Baudot N, Jaffiol C, Robin M & Mauvais-Jarvis P (1979). Male pseudohermaphroditism: a comparative study of one case of 5α-reductase deficiency with three complete forms of testicular feminization. Journal of Clinical Endocrinology and Metabolism, 49: 861-865.
7. Hibberts NA, Howell AE & Randall VA (1998). Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. Journal of Endocrinology, 156: 59-65.
8. Mowszowicz I, Melanitou E, Doukani A, Wright F, Kuttenn F & Mauvais-Jarvis P (1983). Androgen binding capacity and 5[alpha]-reductase activity in pubic skin fibroblasts from hirsute patients. Journal of Clinical Endocrinology and Metabolism, 56: 1209-1213.
9. Oliveira IO, Lhullier C, Brum IS & Spritzer PM (2003). Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women. Steroids (in press).
10. Randall VA (1994). Androgens and human hair growth. Clinical Endocrinology, 40: 439-457.
11. Hay JB & Hodgins MB (1973). Metabolism of androgens in vitro by human facial and axillary skin. Journal of Endocrinology, 59: 475-486.
12. Takayasu S, Wakimoto H, Itami S & Sano S (1980). Activity of testosterone 5α-reductase in various tissues of human skin. Journal of Investigative Dermatology, 74: 187-191.
13. Andersson S, Bischop RW & Russell DW (1989). Expression, cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation, Journal of Biological Chemistry, 264: 16249-16255.
14. Andersson S, Berman DM, Jenkins EP & Russell DW (1991). Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature, 354: 159-161.
15. Harris G, Azzolina B, Baginsky W, Cimis G, Rasmusson G, Tolman R, Raetz C & Ellsworth K (1992). Identification and selective inhibition of an isoenzyme of steroid 5α-reductase in human scalp. Proceedings of the National Academy of Sciences, USA, 89: 10787-10791.
16. Lobo RA, Goebelsmann U & Horton R (1983). Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 57: 393-397.
17. Serafini P & Lobo RA (1985). Increased 5[alpha]-reductase activity in idiopathic hirsutism. Fertility and Sterility, 43: 74-78.
18. Mestayer CH, Berthaut I, Portois M-C, Wright F, Kuttenn F, Mowszowicz I & Mauvais-Jarvis P (1996). Predominant expression of 5α-reductase type 1 in pubic skin from normal subjects and hirsute patients. Journal of Clinical Endocrinology and Metabolism, 81: 1989-1993.
19. Luu-The V, Sugimoto Y, Puy L, Labrie Y, Solache IL, Singh M & Labrie F (1994). Characterization, expression, and immunohistochemical localization of 5α-reductase in human skin. Journal of Investigative Dermatology, 102: 221-226.
20. Eicheler W, Dreher M, Hoffmann R, Happle R & Aumüller G (1995). Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. British Journal of Dermatology, 133: 371-376.
21. Chen W, Zouboulis CC, Fritsch M, Blume-Peytavi U, Kodelja V, Goerdt S, Luu-The V & Orfanos CE (1998). Evidence of heterogeneity and quantitative differences of the type 1 5α-reductase expression in cultured human skin cells: evidence of its presence in melanocytes. Journal of Investigative Dermatology, 110: 84-89.
22. Bayne EK, Flanagan J, Einstein M et al. (1999). Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp. British Journal of Dermatology, 141: 481-491.
23. Sawaya ME & Price VH (1997). Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. Journal of Investigative Dermatology, 109: 296-300.
24. Courchay G, Boyera N, Bernard BA & Mahe Y (1996). Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit. Skin Pharmacology, 9: 169-176.
25. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J & Jacobs HC 1985. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet, 2: 1375-1379.
26. Herter LD, Magalhães JA & Spritzer PM (1996). Relevance of the determination of ovarian volume in adolescent girls with menstrual disorders. Journal of Clinical Ultrasound, 24: 243-248.
27. Spritzer PM, Oppermann-Lisboa K, Mattiello S & Lhullier F (2000). Use of spironolactone as a single agent for long-term therapy of hirsute patients. Clinical Endocrinology, 52: 587-594.
28. Spritzer PM, Billaud L, Thalabard J, Kuttenn F & Mauvais-Jarvis P (1990). Cyproterone acetate versus hydrocortisone treatment in late onset adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 70: 642-645.
29. Azziz R, Dewailly D & Owerbach D (1994). Non-classic adrenal hyperplasia: current concepts. Journal of Clinical Endocrinology and Metabolism, 78: 810-815.
30. Ferriman D & Gallwey JD (1961). Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism, 21: 1140-1148.
31. Reis FM, Maia AL, Ribeiro MFM & Spritzer PM (1999). Progestin modulation of c-fos and prolactin gene expression in the human endometrium. Fertility and Sterility, 71: 1125-1132.
32. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN & Balk SP (1995). Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. New England Journal of Medicine, 332: 1393-1398.
33. Eicheler W, Huth A, Happle R & Hoffmann R (1996). RNA-levels of 5α-reductase and androgen receptor in human skin, hair follicles and follicle-derived cells. In: Van Neste DJJ & Randall VA (Editors), Hair Research for the Next Millenium. Elsevier Science, Amsterdam, 327-331.
34. Schweikert HU & Wilson JD (1974). Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs. Journal of Clinical Endocrinology and Metabolism, 38: 811-819.
35. Kaufman KD, Olsen EA, Whiting D et al. (1998). Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. Journal of the American Academy of Dermatology, 39: 578-589.
36. Tartagni M, Schonauer LM, De Salvia MA, Cicinelli E, De Pergola G & D'Addario V (2000). Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertility and Sterility, 73: 718-723.
37. Sahin Y, Diller S & Kelestimur F (2001). Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertility and Sterility, 75: 496-500.
38. Rittmaster RS (1994). Finasteride. New England Journal of Medicine, 330: 120-125.
39. Asada Y, Sonoda T, Ojiro M, Kurata S, Sato T, Ezaki T & Takayasu S (2001). 5α-Reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro. Journal of Clinical Endocrinology and Metabolism, 86: 2875-2880.
40. Eicheler W, Happle R & Hoffmann R (1998). 5α-Reductase activity in the human hair follicle concentrates in the dermal papilla, Archives of Dermatological Research, 290: 126-132.